CI Investments Inc. Has $2.99 Million Holdings in SPDR S&P Biotech ETF $XBI

CI Investments Inc. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 62.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 23,379 shares of the exchange traded fund’s stock after selling 38,494 shares during the period. CI Investments Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,986,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wealth Management Partners LLC acquired a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $547,000. Banque Pictet & Cie SA increased its holdings in shares of SPDR S&P Biotech ETF by 24.1% in the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after purchasing an additional 12,595 shares during the period. Apella Capital LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $490,000. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of SPDR S&P Biotech ETF by 106.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after purchasing an additional 13,729 shares in the last quarter. Finally, Keystone Investors PTE Ltd. purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $12,022,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $150.48 on Friday. The firm has a 50 day simple moving average of $144.24 and a 200 day simple moving average of $133.44. SPDR S&P Biotech ETF has a 52 week low of $84.39 and a 52 week high of $165.71. The stock has a market cap of $10.30 billion, a P/E ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.